UroSens urosens.com


UroSens is developing diagnostic immunoassays for the detection of prostate and bladder cancer using urine samples. The Company has a worldwide exclusive license, from Cancer Research Technology, for the exploitation of MCM cancer biomarkers in the diagnosis of bladder and prostate cancer, using quantitative immunoassays. MCM proteins are excellent biomarkers, being directly involved in cell replication and are shed into urine by both prostate and bladder tumours. The ubiquitous nature of MCMs, ...Show all

UroSens is developing diagnostic immunoassays for the detection of prostate and bladder cancer using urine samples. The Company has a worldwide exclusive license, from Cancer Research Technology, for the exploitation of MCM cancer biomarkers in the d...Show all

Company (Alive / Active)

Phone: +44 (0)1223 836 556

Fax:

Babraham Research Campus
Babraham
Cambridge, CB22 3AT
United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
UroSens $1.6M Jun 19, 2013

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related UroSens Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)